NCT06278571Active, not recruiting
Effect of Education With Mobile App on Metabolic Control in Patients With Type 2 Diabetes
Efecto de la educación a través de Una aplicación móvil Con Reforzamiento médico y Nutricional Para Incidir en el Control metabólico, Conocimientos y Estilo de Vida de Los Pacientes Con Diabetes Tipo 2
Source: ClinicalTrials.gov · Last updated 24 Apr 2025
Brief summary (registry, in English)
The objective of this study is to compare the effect of education through a mobile application with medical and nutritional reinforcement on the metabolic control of Mexican patients with type 2 diabetes attending primary care clinics in Mexico. The research question is: What is the effect of education through a mobile application with medical and nutritional reinforcement vs. nutritional and medical reinforcement, versus an educational platform to influence the metabolic control of patients with type 2 diabetes? Multicenter clinical trial in six family medicine units of the Mexican Institute of Social Security. These selected units are: UMF 9, UMF 28, UMF 7, UMF 1, UMF 9 and UMF 10. Patients with type 2 diabetes will be randomly assigned to the educational intervention through the educational site, (n=160 patients), two clinics will be assigned for the use of the mobile App and the educational site (n=160 patients), and two clinics will be part of the control group (n=160 patients).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 480 (actual)
- First submitted
- 16 Feb 2024
- Start date
- 30 Jan 2023
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Coordinación de Investigación en Salud, Mexico
- Diseases
- Type 2 diabetes
- NCT number
- NCT06278571
What you commit to
- Study type: Interventional
- Participants enrolled: 480
- From 30 Jan 2023 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- chronic kidney disease with renal replacement therapy
- cancer
Other
- blindness
- lower limb amputation
Who the study is looking for
- Patients with type 2 diabetes.
- Enrolled as beneficiaries of the Mexican Social Security Institute.
- With HbA1 greater than 7% and less than 13%.
- With and without pharmacological treatment for diabetes (hypoglycemic agents or insulin).
- Who can read and write.
- With ≤ 60 years of age7.
- With ≤10 years of diabetes diagnosis.
Age in the registry: 20 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Mexicano del Seguro Social Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.